Skip to content

Mycoprotein and Pea Protein Blend and Muscle Protein Synthetic Response

Comparing Postprandial Muscle Protein Synthesis Rates Following the Consumption of Mycoprotein, Pea Protein and a Mycoprotein/Pea Protein Blend in Resistance Trained Individuals

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04894747
Acronym
BPM
Enrollment
33
Registered
2021-05-20
Start date
2021-05-01
Completion date
2022-06-15
Last updated
2023-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Muscle Protein Synthesis

Brief summary

Dietary protein is vital for the preservation of health and optimal adaptation to training. Plant proteins are considered inferior to animal proteins with respect to their ability to stimulate an acute muscle building response and therefore support long-term muscle reconditioning. Pea protein is a highly commercially available plant proteins source (available as supplements, food ingredients etc.), yet there is no research investigating its ability to stimulate a muscle building response. The investigators aim to assess the effect of consuming pea protein on muscle protein synthesis rates and compare these results to mycoprotein, a source known to elicit a robust anabolic response. Pea protein is lower in some of the essential amino acids, namely methionine, which could mean it is less effective compared with mycoprotein which has a more complete amino acid profile. So in addition to comparing pea with mycoprotein, the investigators also want to compare to a blend of pea and mycoprotein to see if replenishing the amino acid content in pea 'rescues' the anabolic response.

Interventions

DIETARY_SUPPLEMENTBolus ingestion of protein

Ingestion of 25g of protein

Sponsors

Quorn
CollaboratorINDUSTRY
University of Exeter
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* BMI between 18 and 30 * Resistance trained

Exclusion criteria

* Any metabolic impairment * Smoking * Use of over the counter pharmaceuticals (excluding oral contraceptives and contraceptive devices). * A personal family history of epilepsy, seizures or schizophrenia. * Allergic to Quorn/mycoprotein/edible fungi/environmental mould products. * Any motor disorder.

Design outcomes

Primary

MeasureTime frameDescription
Muscle protein synthesis8.5 hoursThe rate of synthesis of new muscle protein (Fractional synthetic rate %/h)

Secondary

MeasureTime frameDescription
Translocation of mTOR via immunohistochemistry8.5 hoursLocality of mTOR within the muscle cell
mTOR phosphorylation via ATP kinase assay8.5 hoursThe amount of mTOR that has been activated in the muscle cell
Plasma amino acid kinetics8.5 hoursThe appearance of amino acids from the protein drink in the circulation.
Serum insulin concentrations8.5 hoursBasal and postprandial concentrations of serum insulin

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026